98%
921
2 minutes
20
Background: Despite the huge youth population, there is a lack of psychiatric diagnostic instruments with reported psychometric properties in Chinese. This study reports the development of the Chinese version of DISC-IV and examines its test-retest reliability.
Method: Seventy-eight parents and 79 youths (mean age 13.1 years) attending child psychiatric clinics were interviewed twice using the Chinese DISC-IV (Diagnostic Interview Schedule for Children-IV) about 22 days apart.
Results: The kappa coefficients were good to excellent for obsessive compulsive disorder (OCD) (both youth (Y) and parent (P) versions), major depressive disorder (MDD) (P), attention deficit hyperactivity disorder (ADHD) (P); fair for anxiety disorder (P), oppositional defiant disorder (ODD) (P, Y), MDD (Y); but poor for anxiety disorder (Y) and ADHD (Y). Parent informants had better test-retest reliability than youth informants.
Conclusions: The Chinese DISC-IV had comparable test-retest reliability with the original English version.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1469-7610.2005.01435.x | DOI Listing |
J Glaucoma
September 2025
Department of Ophthalmology, Kurashiki Medical Center, Kurashiki, Okayama, Japan.
Prcis: Protocol 30-2 of Melbourne Rapid Fields, online computer perimetry, provides a portable, reliable, and patient-friendly alternative to Humphrey Field Analyzer 30-2 SITA fast protocol for Japanese all severity stages of glaucoma patients.
Purpose: Melbourne Rapid Fields (MRF) online computer perimetry is a web-browser-based software that offers white-on-white threshold perimetry using any computer. This study evaluates the perimetric results of 30-2 protocol from MRF performed using a laptop computer in comparison to Humphrey Field Analyzer (HFA).
J Vis
September 2025
Vrije Universiteit Amsterdam, Amsterdam Movement Sciences and Institute Brain and Behaviour Amsterdam (iBBA), Faculty of Behavioural and Movement Sciences, Amsterdam, Netherlands.
Eye tracking has the potential to be used as a meaningful measure of the consequences of vision impairment (VI), yet a comprehensive test battery is lacking. In this study, we sought to evaluate the feasibility and validity of a test battery of eye movements as a tool to measure visual performance in individuals with VI. A test battery including fixation stability, smooth pursuit, saccades, free viewing, and visual search was administered to 46 athletes with VI and 10 control participants.
View Article and Find Full Text PDFJ Refract Surg
September 2025
From the Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Purpose: To determine the accuracy of a new machine learning-based open-source IOL formula (PEARLS-DGS) in 100 patients who underwent uncomplicated cataract surgery and had a history of laser refractive surgery for myopic defects.
Methods: The setting for this retrospective study was HUMANITAS Research Hospital, Milan, Italy. Data from 100 patients with a history of photorefractive keratectomy or laser in situ keratomileusis were retrospectively analyzed to assess the accuracy of the formula.
Rhinology
September 2025
Department of Otolaryngology, Centre of Postgraduate Medical Education, Warsaw, Poland.
Background: Smell tests in children need to be standardized and validated, include odors familiar to children, and be defined by age-dependent standards. This study aimed to adapt the Sniffin Kids Test (SKT) for Polish children and conduct validation and evaluation of the Sniffin Kids Poland Test (SKPOL).
Methodology: The study included 382 children (4-14 years old) recruited in Poland, who were allocated into healthy (n=343) and sick (with subjective olfactory disorders, n=39), divided into 3 age subgroups, but also 13 anosmic children with Kallmann syndrome (KS) and olfactory bulb aplasia.
BMJ Oncol
August 2025
Radiation Medicine Program, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.
Background: The advent of artificial intelligence (AI) tools in oncology to support clinical decision-making, reduce physician workload and automate workflow inefficiencies yields both great promise and caution. To generate high-quality evidence on the safety and efficacy of AI interventions, randomised controlled trials (RCTs) remain the gold standard. However, the completeness and quality of reporting among AI trials in oncology remains unknown.
View Article and Find Full Text PDF